Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Free Radical Biology & Medicine

• Publication date

  2011-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.freeradbiomed.2010.10.710PMID 21047550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-&bgr;/&dgr; ATTENUATES MYOCARDIAL ISCHEMIA/REPERFUSION INJURY IN THE RAT

  2010cited by this paper
• Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes.

  2009cited by this paper
• Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.

  2009cited by this paper
• Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release

  2009cited by this paper
• Peroxisome Proliferator-Activated Receptor-α Contributes to the Resolution of Inflammation after Renal Ischemia/Reperfusion Injury

  2009cited by this paper
• Acute kidney injury increases risk of ESRD among elderly.

  2009cited by this paper
• A rapid urine test for early detection of kidney injury.

  2009cited by this paper
• Targeting adhesion molecules in cardiovascular disorders.

  2008cited by this paper
• Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor β/δ (NR1C2) Antagonist

  2008cited by this paper
• Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.

  2008influential reference
• Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction

  2008cited by this paper
• Generation of endogenous hydrogen sulphide by cystathionine gamma-lyase limits renal ischaemia/reperfusion injury and dysfunction

  2008cited by this paper
• IL-18 contributes to renal damage after ischemia-reperfusion.

  2008cited by this paper
• The role of interleukin-18 in renal injury.

  2008cited by this paper
• Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning.

  2008cited by this paper
• IL‐1, IL‐18, and IL‐33 families of cytokines

  2008cited by this paper
• Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742

  2008cited by this paper
• Can the Protective Actions of JAK-STAT in the Heart be Exploited Therapeutically? Parsing the Regulation of Interleukin-6-Type Cytokine Signaling

  2007cited by this paper
• Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury.

  2007cited by this paper
• Protective Effects of Chronic Melatonin Treatment Against Renal Ischemia/Reperfusion Injury in Streptozotocin-Induced Diabetic Rats

  2007cited by this paper
• The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo.

  2007cited by this paper
• Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review

  2007cited by this paper
• SOCS proteins, cytokine signalling and immune regulation

  2007cited by this paper
• Normotensive ischemic acute renal failure.

  2007influential reference
• Normotensive ischemic acute renal failure.

  2007cited by this paper
• The PPARδ agonist GW501516 suppresses interleukin‐6‐mediated hepatocyte acute phase reaction via STAT3 inhibition

  2007cited by this paper
• Inflammation and metabolic disorders

  2006cited by this paper
• Ischemia-Induced Renal Expression of Hyaluronan and CD44 in Diabetic Rats

  2006cited by this paper
• Peroxisome proliferator activated

  2006cited by this paper
• Endogenous Interleukin-6 Enhances the Renal Injury, Dysfunction, and Inflammation Caused by Ischemia/Reperfusion

  2005cited by this paper
• Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.

  2005influential reference
• Maladaptive role of IL-6 in ischemic acute renal failure.

  2005cited by this paper
• The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion.

  2005cited by this paper
• Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.

  2005cited by this paper
• Risk factors for acute renal failure: inherent and modifiable risks

  2005cited by this paper
• Inflammatory cells in ischemic acute renal failure.

  2004cited by this paper
• PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.

  2004cited by this paper
• Causes and Prognosis of Nontraumatic Acute Renal Failure Requiring Dialysis in Adult Patients with and without Diabetes

  2004cited by this paper
• Hyperglycaemia and renal ischaemia-reperfusion injury.

  2003cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity

  2003cited by this paper
• An in vivo model of ischemia/reperfusion and inflammation of the kidneys of the rat.

  2003cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.

  2003cited by this paper
• Suppressors of cytokine signalling (SOCS) in the immune system

  2002cited by this paper
• Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.

  2002cited by this paper
• The mechanisms of action of PPARs.

  2002cited by this paper
• Protective effect of insulin on ischemic renal injury in diabetes mellitus.

  2002cited by this paper
• Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.

  2002influential reference
• Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney.

  1999cited by this paper
• Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

  1982cited by this paper
• Improved method for specific determination of creatinine in serum and urine.

  1973cited by this paper

• Axin formation inhibitor 1 aggravates hepatic ischemia‒reperfusion injury by promoting the ubiquitination and degradation of PPARβ

  2025cites this paper
• KLF15 ATTENUATES LIPOPOLYSACCHARIDE-INDUCED APOPTOSIS AND INFLAMMATORY RESPONSE IN RENAL TUBULAR EPITHELIAL CELLS VIA PPARΔ

  2024cites this paper
• Amlodipine protects against methotrexate nephrotoxicity by modulating inflammation, oxidative stress, and apoptosis through NF-κB/PPAR-β/caspase 3 pathways

  2024cites this paper
• Change in production of transcription factors and postgenomic protein modification in different complications of pregnancy

  2022cites this paper
• Nuclear receptors in renal health and disease

  2022cites this paper
• PPARβ/δ Augments IL-1β-Induced COX-2 Expression and PGE2 Biosynthesis in Human Mesangial Cells via the Activation of SIRT1

  2022cites this paper
• The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases

  2022cites this paper
• Lipidomics Provides New Insight into Pathogenesis and Therapeutic Targets of the Ischemia—Reperfusion Injury

  2021cites this paper
• Hydralazine attenuates renal inflammation in diabetic rats with ischemia/reperfusion acute kidney injury.

  2021cites this paper
• Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2

  2020cites this paper
• Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2

  2020cites this paper
• Nuclear receptors in the kidney during health and disease.

  2020cites this paper
• Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor-α levels.

  2019cites this paper
• Preclinical septic shock research: why we need an animal ICU

  2019cites this paper
• Scavenging Circulating Mitochondrial DNA as a Potential Therapeutic Option for Multiple Organ Dysfunction in Trauma Hemorrhage

  2018cites this paper
• PPAR-δ Agonist With Mesenchymal Stem Cells Induces Type II Collagen-Producing Chondrocytes in Human Arthritic Synovial Fluid

  2017cites this paper
• Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats

  2017cites this paper
• Activation of Peroxisome Proliferator Activator Receptor &bgr;/&dgr; Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus

  2017cites this paper
• Thioredoxin-Interacting Protein Mediates NLRP3 Inflammasome Activation Involved in the Susceptibility to Ischemic Acute Kidney Injury in Diabetes

  2016cites this paper
• Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.

  2016cites this paper
• Sodium Intake Regulates Glucose Homeostasis through the PPARδ/Adiponectin-Mediated SGLT2 Pathway.

  2016cites this paper
• Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury.

  2016cites this paper
• A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion

  2015cites this paper
• PPARs as Modulators of Cardiac Metabolism and Inflammation

  2015cites this paper
• Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function

  2015cites this paper
• Inhibition of Glutathione S-Transferase by Ethacrynic Acid Augments Ischemia-Reperfusion Damage and Apoptosis and Attenuates the Positive Effect of Ischemic Postconditioning in a Bilateral Acute Hindlimb Ischemia Rat Model

  2015cites this paper
• Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney

  2014cites this paper
• Physiological functions of peroxisome proliferator-activated receptor β.

  2014cites this paper
• Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

  2013cites this paper
• Cardiac Peroxisome Proliferator-Activated Receptor δ (PPARδ) as a New Target for Increased Contractility without Altering Heart Rate

  2013cites this paper
• Peroxisome Proliferator-Activated Receptor δ Agonist, HPP593, Prevents Renal Necrosis under Chronic Ischemia

  2013cites this paper
• Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation.

  2013cites this paper
• The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats.

  2013cites this paper
• Acute treatment with relaxin attenuates the injury/dysfunction induced by renal ischemia/reperfusion injury.

  2013cites this paper
• Effects of the PPAR-β/δ agonist GW0742 during resuscitated porcine septic shock

  2013influential citation
• Activation of Receptors δ (PPARδ) by Agonist (GW0742) may Enhance Lipid Metabolism in Heart both In Vivo and In Vitro

  2013cites this paper
• Progress in the development of animal models of acute kidney injury and its impact on drug discovery

  2013cites this paper
• SOCS and diabetes—ups and downs of a turbulent relationship

  2013cites this paper
• Protection Against Renal Ischemia-Reperfusion Injury by Ischemic Postconditioning

  2013cites this paper
• PPAR β/δ agonist attenuates myocardial ischemia- reperfusion injury in mice

  2013cites this paper
• Anti-inflammatory and anti-hyperalgesic effect of all-trans retinoic acid in carrageenan-induced paw edema in Wistar rats: Involvement of peroxisome proliferator-activated receptor-β/δ receptors

  2013cites this paper
• АКТИВИРУЮЩИХ ПРОЛИФЕРАЦИЮ ФИЗИОЛОГИИ ПАТОЛОГИИ ПОЧЕК PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS IN KIDNEY PHYSIOLOGY AND PATHOLOGY

  2013cites this paper
• Role of TNF-α in Renal Damage in Mice Showing Hepatic Steatosis Induced by High Fat Diet

  2012cites this paper
• Differential regulation of stimulated glucose transport by free fatty acids and PPARα or -δ agonists in cardiac myocytes.

  2012cites this paper
• Reduced expression of PPAR-β/δ limits the potential beneficial effects of GW0742 during septic shock in atherosclerotic swine

  2012cites this paper
• Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.

  2012cites this paper
• Activation of Farnesoid X Receptor Increases the Expression of Cytokine Inducible SH2-Containing Protein in HepG2 Cells

  2012cites this paper
• FXR ligands protect against hepatocellular inflammation via SOCS3 induction.

  2012cites this paper
• New Insights into the Role of Peroxisome Proliferator-Activated Receptors in Regulating the Inflammatory Response after Tissue Injury

  2012cites this paper
• Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).

  2011cites this paper
• The role of PPAR in myocardial response to ischemia in normal and diseased heart.

  2011cites this paper